BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...Epigenetics Corp. Cancer ZEN-3694 BET bromodomain proteins Metastatic castration-resistant prostate cancer (CRPC) Phase I $40.9 Eastern Capital...
BioCentury | Jun 23, 2017
Financial News

Resverlogix completes private placement and overnight marketed equity offering

...two-part offering which closed on June 20. Resverlogix sold 3 million units to existing investors Eastern Capital...
BioCentury | May 23, 2016
Financial News

Zenith Epigenetics completes venture financing

...Calgary, Alberta Business: Autoimmune, Cancer Date completed: 2016-05-16 Type: Venture financing Raised: $24.6 million Investor: Eastern Capital WIR...
BioCentury | Jul 27, 2015
Financial News

Resverlogix completes private placement of units

...Price: C$2.67 (unit) Shares after offering: 105.1 million Investors: Shenzhen Hepalink Pharmaceutical Co. Ltd. ; Eastern Capital...
BioCentury | Jun 29, 2015
Financial News

Highland Therapeutics completes venture financing

...Toronto, Ontario Business: Drug delivery Date completed: 2015-06-24 Type: Venture financing Raised: $25 million Investor: Eastern Capital WIR...
BioCentury | Jun 29, 2015
Financial News

TapImmune completes warrant exercise

...exercise Raised: $2.5 million Shares: 5 million Price: $0.50 Shares after offering: 37.6 million Investor: Eastern Capital WIR...
BioCentury | Jun 27, 2015
Financial News

Highland raises $25M in venture round

...Highland Therapeutics Inc. (Toronto, Ontario) raised $25 million in a venture round led by Eastern Capital. Highland...
BioCentury | May 4, 2015
Company News

Resverlogix, Shenzhen Hepalink Pharmaceutical deal

...responsible for development costs in the regions. Subject to the completion of the transaction, shareholder Eastern Capital...
BioCentury | May 4, 2015
Financial News

Mirna completes venture financing

...Texas Business: Cancer Date completed: 2015-04-30 Type: Venture financing Raised: $41.8 million Investors: Baxter Ventures; Eastern Capital...
BioCentury | May 1, 2015
Financial News

Mirna raises $41.8M in series D

...in a series D round led by new investor Baxter Ventures. Other new investors included Eastern Capital...
Items per page:
1 - 10 of 25
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...Epigenetics Corp. Cancer ZEN-3694 BET bromodomain proteins Metastatic castration-resistant prostate cancer (CRPC) Phase I $40.9 Eastern Capital...
BioCentury | Jun 23, 2017
Financial News

Resverlogix completes private placement and overnight marketed equity offering

...two-part offering which closed on June 20. Resverlogix sold 3 million units to existing investors Eastern Capital...
BioCentury | May 23, 2016
Financial News

Zenith Epigenetics completes venture financing

...Calgary, Alberta Business: Autoimmune, Cancer Date completed: 2016-05-16 Type: Venture financing Raised: $24.6 million Investor: Eastern Capital WIR...
BioCentury | Jul 27, 2015
Financial News

Resverlogix completes private placement of units

...Price: C$2.67 (unit) Shares after offering: 105.1 million Investors: Shenzhen Hepalink Pharmaceutical Co. Ltd. ; Eastern Capital...
BioCentury | Jun 29, 2015
Financial News

Highland Therapeutics completes venture financing

...Toronto, Ontario Business: Drug delivery Date completed: 2015-06-24 Type: Venture financing Raised: $25 million Investor: Eastern Capital WIR...
BioCentury | Jun 29, 2015
Financial News

TapImmune completes warrant exercise

...exercise Raised: $2.5 million Shares: 5 million Price: $0.50 Shares after offering: 37.6 million Investor: Eastern Capital WIR...
BioCentury | Jun 27, 2015
Financial News

Highland raises $25M in venture round

...Highland Therapeutics Inc. (Toronto, Ontario) raised $25 million in a venture round led by Eastern Capital. Highland...
BioCentury | May 4, 2015
Company News

Resverlogix, Shenzhen Hepalink Pharmaceutical deal

...responsible for development costs in the regions. Subject to the completion of the transaction, shareholder Eastern Capital...
BioCentury | May 4, 2015
Financial News

Mirna completes venture financing

...Texas Business: Cancer Date completed: 2015-04-30 Type: Venture financing Raised: $41.8 million Investors: Baxter Ventures; Eastern Capital...
BioCentury | May 1, 2015
Financial News

Mirna raises $41.8M in series D

...in a series D round led by new investor Baxter Ventures. Other new investors included Eastern Capital...
Items per page:
1 - 10 of 25